Profile of dupilumab and its potential in the treatment of inadequately controlled moderate-to-severe atopic dermatitis

Olabola Awosika,1 Lori Kim,2 Momina Mazhar,2 Monica Rengifo-Pardo,1,2 Alison Ehrlich1,2 1Department of Dermatology, The George Washington Medical Faculty Associates, Washington, DC, USA; 2George Washington University School of Medicine & Health Sciences, Washington, DC, USA Abstract: Atopic derm...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Awosika O, Kim L, Mazhar M, Rengifo-Pardo M, Ehrlich A
Format:	Artigo
Jezik:	Inglês
Izdano:	Dove Medical Press 2018-01-01
Serija:	Clinical, Cosmetic and Investigational Dermatology
Teme:	atopic dermatitis dupilumab IL-4 IL-13 biologics
Online dostop:	https://www.dovepress.com/profile-of-dupilumab-and-its-potential-in-the-treatment-of-inadequatel-peer-reviewed-article-CCID
Oznake:	Označite Brez oznak, prvi označite!